GlassScriptPhysician profile
Tyler Roberts
NPI 1346658945
$3,302.56
in general payments reported to CMS, 2019-2025
18 companies · $981 in 2025
The $981 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $12.69 · 2021: $687 · 2022: $1,099 · 2023: $152 · 2024: $159 · 2025: $981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,143 · Consulting Fee: $100 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,142.57 |
| Consulting Fee | $100.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Notal Vision, INC. | $642.34 | 2022 | |
| Sun Pharmaceutical Industries INC. | $487.78 | 2021-2025 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $423.96 | 2021-2022 | |
| Alcon Vision LLC | $296.99 | 2021-2025 | Air Optix, Tryptyr |
| Coopervision INC. | $217.35 | 2019-2025 | Clariti Contact Lens |
| Mallinckrodt Hospital Products INC. | $163.60 | 2025 | Acthar |
| Biotissue Holdings INC. | $160.44 | 2024-2025 | |
| Ocular Therapeutix, INC. | $128.59 | 2024 | |
| Dompe US, INC. | $124.91 | 2025 | Oxervate |
| Ani Pharmaceuticals, INC. | $124.90 | 2025 | Purified Cortrophin Gel |
| Bausch & Lomb Americas INC. | $115.50 | 2023-2025 | Infuse |
| Abbvie INC. | $106.20 | 2022-2025 | |
| Oyster Point Pharma, INC. | $86.74 | 2022-2025 | Ryzumvi, Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $76.85 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $50.00 | 2025 | Acuvue |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $49.95 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $34.32 | 2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.